Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
Authors:
- J. CompstonJ. Compston
- C. BowringCBC. Bowring
- A. CooperACA. Cooper
- C. CooperC. Cooper
- C. DaviesCDC. Davies
- R. FrancisRFR. Francis
- J.A. KanisJKJ.A. Kanis
- D. MarshDMD. Marsh
- E.V. McCloskeyEME.V. McCloskey
- D.M. ReidDRD.M. Reid
- P. SelbyP. Selby
Top Cited Papers
- 1 August 2013
- Vol. 75 (4) , 392-396
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg)Heart, 2012
- Does osteoporosis therapy invalidate FRAX for fracture prediction?Journal of Bone and Mineral Research, 2012
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2011
- Do calcium plus vitamin D supplements increase cardiovascular risk?BMJ, 2011
- Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysisBMJ, 2011
- Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysisBMJ, 2010
- Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UKMaturitas, 2009
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UKOsteoporosis International, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Fracture risk remains reduced one year after discontinuation of risedronateOsteoporosis International, 2007